SmartCells, Inc. Secures $1,000,000 New Funding

  • Feed Type
  • Date
    10/22/2008
  • Company Name
    SmartCells, Inc.
  • Mailing Address
    100 Cummings Center Beverly, MA 01915
  • Company Description
    SmartInsulin™ consists of a layered, biocompatible and biodegradable polymer-therapeutic that is bound to an engineered glucose-binding molecule. Insulin is released from SmartInsulin only when the therapeutic is unbound by the presence of a specific glucose concentration.
  • Website
    http://www.smartinsulin.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This investment will accelerate the commercial development of our SmartInsulin therapy for type 1 diabetes.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy